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Abstract
Background:  To date, few epidemiologic studies have examined the relationship between
environmental PCDD/F exposure and breast cancer in human populations. Dioxin emissions from
municipal solid waste incinerators (MSWIs) are one of the major sources of environmental dioxins
and are therefore an exposure source of public concern. The purpose of this study was to examine
the association between dioxins emitted from a polluting MSWI and invasive breast cancer risk
among women residing in the area under direct influence of the facility.
Methods: We compared 434 incident cases of invasive breast cancer diagnosed between 1996 and
2002, and 2170 controls randomly selected from the 1999 population census. A validated
dispersion model was used as a proxy for dioxin exposure, yielding four exposure categories. The
latter were linked to individual places of residence, using Geographic Information System
technology.
Results: The age distribution at diagnosis for all cases combined showed a bimodal pattern with
incidence peaks near 50 and 70 years old. This prompted us to run models separately for women
aged 20–59 years, and women aged 60 years or older. Among women younger than 60 years old,
no increased or decreased risk was found for any dioxin exposure category. Conversely, women
over 60 years old living in the highest exposed zone were 0.31 time less likely (95% confidence
interval, 0.08–0.89) to develop invasive breast cancer.
Conclusion: Before speculating that this decreased risk reflects a dioxin anti-estrogenic activity
with greater effect on late-onset acquired breast cancer, some residual confounding must be
envisaged.
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Background
Established risk factors for breast cancer are hormonally
mediated: age, family history of breast cancer, early
menarche, late menopause, late first full-term pregnancy
or nulliparity, breast density, and benign breast disease
[1,2]. But taken together, these well-established risk fac-
tors account for only about half of all breast cancer cases
[3]. Considerable interest has therefore recently focused
on environmental contaminants having the potential to
affect breast cancer risk, although explicit environmental
links to this disease are still limited.
Dioxin is the name given to two classes of organochlorine
compounds; 75 polychlorinated dibenzo-p-dioxins
(PCDD) and 135 polychlorinated dibenzofurans (PCDF).
Seventeen tetrachloro-substituted congeners are toxic,
with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) being
the most potent. The U.S. Environmental Protection
Agency and the International Agency for Research on Can-
cer have classified TCDD as a human carcinogen [4,5].
This compound is also known to disrupt multiendocrine
pathways in animals at body burdens which are close to
those present in the background human population [6].
TCDD elicits a number of anti-estrogenic responses in the
female reproductive tract, including the impairment of
mammary gland differentiation (without blocking the
response to exogenous estrogen) in the post pubertal
female rat [7], the inhibition of estrogen-induced growth
of human mammary cells, and carcinogen-induced mam-
mary cancer in rats [8], the suppression of estrogen-
dependent development of mammary cancer in mice
bearing breast cancer cell xenografts [8,9], and the inhibi-
tion of the breast cancer progression [10].
However, accumulating evidence suggests that TCDD also
possesses estrogen-like activity. TCCD induces an estro-
gen-like gene expression profile in the uteri of immature
ovariectomized mice in the absence of histopathological
or morphological manifestations [11], and mediates the
induction of estrogen dependent tumors in rat [12,13].
The opposing actions of TCDD, anti-estrogenic in the
presence of estrogen and estrogenic in its absence, suggest
that the effects of TCDD may vary depending on develop-
mental stage at exposure [11]. The ability of TCDD to
cause ovarian tumors could also dependent on initiation,
length of promotion, and age of the animal when exposed
and evaluated [13].
To date, few epidemiologic studies have examined the
relationship between PCDD/Fs and breast cancer in
human populations. Most of these have consisted of occu-
pational cohorts yielding conflicting results [14]. Warner
et al. have recently conducted a retrospective cohort study
to examine the association between serum TCDD levels
and breast cancer risk in women residing around Seveso,
Italy, in 1976, at the time of an industrial explosion that
resulted in the highest known population exposure to
TCDD [15]. Twenty years later, the relative risk for breast
cancer associated with a 10-fold increase in serum log10
TCDD levels was significantly increased by 2.1-fold (95%
confidence interval [CI], 1.0–4.6), while adjusting for
established breast cancer risk factors.
Dioxin emissions from municipal solid waste incinerators
(MSWIs) are one of the major sources of environmental
dioxins and are therefore an exposure source of public
concern. Our team recently detected a cluster of non-
Hodgkin lymphoma (NHL) in an area that contains a
MSWI with high dioxin emission levels (Besançon,
France) [16]. We subsequently found a 2.3-fold risk (95%
CI, 1.4 – 3.8) for NHL associated with residence in areas
classified as highly exposed to dioxin emitted from this
MSWI, while adjusting for a wide range of socio-economic
characteristics at the block group level [17].
Both the suggestive results by Warner et al. [15], and the
availability of a validated dispersion model as a proxy for
dioxin exposure, prompted us to carry out a population-
based case-control study focusing on breast cancer in the
vicinity of this MSWI.
Methods
Study area
The MSWI under investigation has been fully described
elsewhere [18]. Situated near the southwest boundary of
Besançon (4 km from the city center), and put into service
in 1971, it had a capacity of 7.2 metric tons per hour. In
1998, approximately 67,000 metric tons of waste were
processed there. Some legal guidelines for incinerator
emissions have not been followed at this location. For
example, in 1997, exhaust gases were not maintained at
temperatures of more than 850°C for the legal time (>2
s), allowing dioxins to be emitted. The first time that the
dioxin concentration of an exhaust gas was ever measured
(in December 1997), it was found to be 16.3 ng interna-
tional toxic equivalency factor (I-TEQ)/m3, whereas the
European guide value is 0.1 ng I-TEQ/m3. With such con-
ditions, it could be expected that in the last two decades
remarkable amounts of PCDD/Fs were released into the
environment.
Since a dispersion model provided a reliable proxy for
dioxin exposure on the northeast side of the MSWI (sim-
ple terrain), but not in the southwest direction (complex
terrain) [18], the 90 blocks located southwest of the MSWI
were excluded, leaving 590 blocks as the study area.International Journal of Health Geographics 2008, 7:4 http://www.ij-healthgeographics.com/content/7/1/4
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Selection of cases and controls
Invasive breast cancer incidence data were provided by the
Doubs cancer registry. The latter was established in 1977
and is complete for breast cancer cases, as ascertained by
the ratio of the number of deaths to the number of cases
registered during 1993–1997, which at 32% (for the
Doubs region) is very similar to those reported in other
Western countries [19]. Virtually all cases were histologi-
cally verified (97%). Cancer registry procedures are
approved by the French National Cancer Registry Com-
mittee and the National Commission for the Confidenti-
ality of Computerized Data. Women aged 20 years and
over, diagnosed during the years 1996 to 2002, and living
in the study area at the time of their diagnosis, were
included. The cancer registry extracted anonymous data
on age and area of residence at time of diagnosis, and his-
topathologic subtype, using the International Classifica-
tion of Disease for Oncology, third edition (ICD-O-3):
infiltrating duct carcinoma of not otherwise specified
(duct NOS; ICD-O-3 code 8500/3), and lobular carci-
noma (ICD-O-3 code 8520/3). For the sake of clarity, the
less common and the unknown histopathological sub-
types (i.e. all other ICD-O-3 breast cancer codes) were
aggregated in an "other or unknown" category. All pri-
mary invasive breast cancers were therefore included.
We selected female controls from a reliable and accessible
database, the 1999 population census. Because of French
privacy laws and confidentiality requirements the only
individual (and anonymous) data available to researchers
are sex, age categories (0–19, 20–39, 40–59, 60–74 and
75+ years), and residence in a given block. The block is the
smallest level of geographic resolution in the French cen-
sus database and is defined only in densely populated
areas. Each block is typically a quadrangle bounded by
four streets. In the 1999 census, there are 590 blocks in
northeast Besançon (averaging 72 female inhabitants
aged 20 years and over), aggregated in 42 block groups
(averaging 1008 female inhabitants aged 20 years and
over). Unfortunately, no other risk factor data at the indi-
vidual or block level are available to researchers. However,
a set of social and demographic information is available
for each block group. We randomly selected age-matched
population-based controls, according to a 5-to-1 match-
ing procedure.
Dioxin exposure modeling
Dioxin exposure assessment has been fully described else-
where [18]. In no instance was actual individual exposure
measured but estimated through exposure zones based on
predicted ground-level air concentrations. Briefly, we took
advantage of a first-generation Gaussian-type dispersion
model (APC3 software, Aria Technologies, Colombes,
France), allowing the modeling of the transport and dis-
persion of dioxin emissions from the MSWI. This model
was originally developed to predict the future impact of
dioxin emissions, both from an old (but renewed) com-
bustion chamber and from a new oven with up-to-date
pollution controls. It was not possible to assess past expo-
sure because past dioxin emission rates had not been col-
lected. However, dispersion modeling is heavily
influenced by factors that are stable over time (mean
meteorological conditions, terrain elevations and stack
height). Thus, we assumed that contour shapes, as derived
from the prediction model, were reliable estimates of past
dioxin deposition profiles and we used dioxin ground-
level concentrations as relative figures rather than abso-
lute figures to estimate past exposure. These geographic-
based exposure categories have been assessed through
PCDD/F measurements from soil samples.
The respective contours of these modeled ground-level air
concentrations (classified as very low, low, intermediate,
and high) were digitized and contoured onto the surface
of the map with geographic information system (GIS)
tools. We then overlaid a map of blocks onto the digital
dioxin concentration map to attribute a dioxin concentra-
tion category to each of the 590 northeast blocks (pro-
vided half or more of their area was within a given
contour) (Figure 1). From their respective residence block,
we then obtained a risk field classification for each cancer
patient and control. Regarding socioeconomic character-
istics defined at the block group level (education, occupa-
tional social class and household-based indicators), we
have already shown that they did not vary with dioxin
exposure category (Table 1) [17].
Statistical analysis
We used conditional logistic regressions to calculate odds
ratios (ORs) and 95% CIs for each level of dioxin expo-
sure estimated from the dispersion model. A set of
dummy variables was generated for this categorical scale
variable using the lowest category as the reference group.
Models were run with LogXact software (CYTEL Software
Corporation, Cambridge, MA, USA).
Results
From 1996 to 2002, a total of 434 invasive breast carcino-
mas was diagnosed in the northeast side of the city of
Besançon, and 2170 population controls were therefore
randomly selected.
These cases corresponded to an age-standardized (world)
incidence rate of 81.4 per 100,000, to be compared to the
age-standardized (world) incidence rate of 90.4 per
100,000 for France, as estimated in 2000 (comparative
morbidity figure [CMF] = 0.90, 95% CI, 0.81–1.00), and
the age-standardized (world) incidence rate of 76.9 per
100,000 for the Doubs region that comprises the city of
Besançon (CMF = 1.06, 95% CI, 0.95–1.18).International Journal of Health Geographics 2008, 7:4 http://www.ij-healthgeographics.com/content/7/1/4
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All but 12 cases were histologically confirmed (97.23%).
Duct NOS and lobular carcinomas were the most com-
mon histologic subtypes accounting for 79.26% and
11.75%, respectively.
The age distribution at diagnosis for all breast cases com-
bined showed a bimodal pattern with incidence peaks (or
modes) near ages 50 and 70 years (Figure 2). This
prompted us to run models separately for women aged
20–59 years, and women aged 60 years or older.
The distributions of these cancer patients by age bands
and dioxin exposure categories are displayed in Table 2.
Among women aged less than 60 years old, no increased
Table 1: Socioeconomic characteristics (defined at the block group level) of dioxin exposure zones (Kruskall – Wallis tests) [17]
Very low Low Intermediate High p-value
Persons with a high school diploma (%) 33.9 30.2 26.6 28.4 0.21
Women in labor force (%) 46.8 49.3 47.6 54.8 0.23
Workers in labor force (%) 16.6 24.1 26.5 23.2 0.08
Unemployed in labor force (%) 12.8 14.8 15.1 12.8 0.84
Single woman as head of household (%) 6.8 7.7 10.6 9.3 0.15
Owner-occupied houses (%) 34.8 32.1 29.1 36.1 0.88
Number of persons per dwelling (mean) 2.25 1.94 2.21 2.25 0.34
Single-family houses (%) 35.1 13.8 12.1 30.4 0.17
Modeled dioxin concentrations at the block level, on the North-East side of the municipal solid waste incinerator of Besançon,  France Figure 1
Modeled dioxin concentrations at the block level, on the North-East side of the municipal solid waste incinerator of Besançon, 
France.
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or decreased risk was found for any dioxin exposure cate-
gory. Conversely, for ages 60 years and over, women living
in the highest exposed zone were 0.31 time less likely
(95% CI, 0.08–0.89) to develop invasive breast carcinoma
than women living in the very low emission area, with no
relative risk estimate different from one for the other
dioxin risk categories.
Excluding the 12 non-histologically confirmed cases did
not alter the findings (results not shown).
Discussion
Overall, our results do not provide evidence for an associ-
ation between dioxins emitted from the MSWI and breast
cancer risk among younger women, but show a decreased
risk among older women residing in areas classified as
highly exposed to dioxins.
Our study has a number of strengths. It is population-
based and involves cases actively identified through mul-
tiple sources within a defined geographic area. Controls
were randomly selected from a complete directory of peo-
ple residing in the same area with a modest but relevant
and reliable list of characteristics available at low cost
(census data). The 5-to-1 matching procedure (usually
considered to be a good trade-off regarding statistical
power), kept constant across strata, produced fairly pre-
cise relative risk estimates, as reflected by the narrowness
of the corresponding confidence intervals (Table 1).
The modeled ground-level concentrations represented the
best available surrogates for past dioxin exposure meas-
urements from the same source, given that no earlier
measurements had been taken. By restricting our survey to
the North East side of the MSWI, we were able to use
dioxin exposure data based on sophisticated methods for
modeling of emissions. GIS tools, in combination with
dioxin soil measurements to validate the generated expo-
sure metrics, allowed the classification of exposure across
the study population, while avoiding the biases and limi-
tations of self-reported exposures.
Regarding other occupational or environmental sources
of exposure to dioxins, there are no adjacent industrial
sources of combustion-effluents; highly polluting indus-
tries were replaced 2 decades ago by small-scale advanced
technologies. No cement kilns, iron or steel works or
foundries are located in this area. Other potential thermal
and combustion sources, such as automobile exhausts
and home heating, result in diffuse emissions. We have
recently confirmed that the MSWI was indeed the single
dominant point source of PCDD/Fs in this area [20].
Despite these strengths, our study has some limitations
worth noting. Controls were residents in 1999, whereas
cases were diagnosed between 1996 and 2002, introduc-
ing a time lag in the sampling for some matched sets.
However, the population of Besançon appears to be stable
over time for the age groups considered; 86% of the peo-
ple over 40 years of age who lived in Besançon in 1999
Age at diagnosis-histogram and density plot (or smoothed  histogram) of invasive breast cancer (women residing on the  North-East side of the municipal solid waste incinerator,  Besançon, France, 1996–2002) Figure 2
Age at diagnosis-histogram and density plot (or smoothed 
histogram) of invasive breast cancer (women residing on the 
North-East side of the municipal solid waste incinerator, 
Besançon, France, 1996–2002).
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Table 2: Odds Ratio and 95% confidence interval of invasive breast 
cancer by age bands and dioxin exposure categories
Dioxin exposure Cases Controls OR* (95% CI†)
Women aged 20–59 years
Very low 41 225 1.0
Low 81 414 1.06 (0.72–1.56)
Intermediate 64 279 1.25 (0.82–1.89)
High 11 67 0.88 (0.43–1.79)
Women aged 60 years and over
Very low 50 228 1.0
Low 111 558 0.90 (0.63–1.29)
Intermediate 72 339 0.96 (0.66–1.41)
High 4 60 0.31 (0.08–0.89)
* odds ratio
† confidence intervalInternational Journal of Health Geographics 2008, 7:4 http://www.ij-healthgeographics.com/content/7/1/4
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were already residing in the city in 1990. Hence, the short-
ness of this time lag should not have affected the coverage
of the target population, and if so, would bias the odds
ratios towards 1.0.
This study is of mixed individual/ecological design with
case and control residences linked to the dispersion map
at the block level. Thus, although census blocks have a
limited area (decreasing the distance between actual and
surrogate locations) and were assigned one of four expo-
sure levels prior to control sampling, the possibility of
some non differential exposure misclassification cannot
be ruled out.
Confounding
Neither interviews nor medical data collection were done
for the 2170 population controls. We only relied on cen-
sus-based data, anonymous and parsimonious to protect
privacy. We could not therefore verify that controls were
"breast cancer free" (but such a misclassification would
bias the odds ratio towards the null). Adjustment for age
was imprecise, due to the width (20 years) of the age cat-
egories used for the control sampling. The lack of infor-
mation pertaining to residence history and time-activity
patterns limited our ability to ascertain the duration of
exposure. Considering the long exposure-to-effect inter-
val, in- and out-migrations may have occurred, inducing a
potential misclassification. However, as migration is
likely to be random with respect to disease status, it would
result in a bias of risk estimates towards the null.
There are many known risk factors for breast cancer that
we were unable to include in our analyses. In particular,
women aged 60 years and above exposed to risk factors
specific to postmenopausal women (body mass index,
natural menopause, hormone therapy, educational level
[2]) could be proportionally less abundant in the highest
exposed zone. Unfortunately, we did not know the local
distribution of these risk factors, and hence, whether they
could explain some of the risk reduction observed in
women aged 60 years and over and residing in the most
exposed zone. Regarding socioeconomic level, a higher
risk of breast cancer has been consistently reported for
women having higher socioeconomic status or living in
affluent communities. But, to confound our results,
women aged 60 years and over living in the high exposure
zone should be less well-off. In this respect, the similari-
ties across bloc groups characterized by differing exposure
levels are reassuring. However, for all the above-men-
tioned reasons, we cannot firmly exclude the possibility
that residual confounding affected the reported odds
ratios.
Age distribution patterns
Our descriptive analysis of this population based data
provides evidence for two main breast cancer popula-
tions, according to age at onset, mixed within breast can-
cer incidence overall. A shift to earlier age at diagnosis
resulting from an increased compliance with screening
mammography recommendations is unlikely, since the
first breast cancer screening campaign in this area started
late 2003.
One breast cancer type was mostly early-onset with peak
incidence near age 50 years. The second breast cancer type
was largely late-onset with its mode occurring at age about
70 years. This bimodal age incidence pattern has been
observed worldwide, suggesting etiologic heterogeneity
due to at least two biological subtypes or causal pathways
[21]. In general, high-risk tumors are surrogates for bimo-
dal breast cancer populations, shifted towards the early-
onset mode near 50 years of age. Low-risk tumors are sur-
rogates for bimodal breast cancer, weighted towards the
late-onset mode at age 70 years. Moreover, bimodality in
the general breast cancer population might be a reflection
of early-onset of hereditary (or familial) versus late-onset
non-hereditary (acquired or sporadic, and then more
likely to be associated with environmental risk factors)
breast cancer types. Additional etiologic clues could be
provided by our contrasted results among women aged 60
years and over, the decreased risk in the most exposed
zone being compatible with dioxin anti-estrogenic activ-
ity.
Dose-response relationship
One striking feature lies in the absence of dose-response
relationship but the presence of a possible threshold effect
at the highest dioxin concentration category (associated
with a decreased breast cancer risk). This threshold effect
was also noticeable for NHL, but with an increased risk
[17]. Unfortunately, as we used a ranking system rather
than quantitative measurements to classify exposure lev-
els we cannot be more precise about this threshold level.
Comparison with other environmental studies
Our results stand in contrast to the findings from two pre-
vious studies. A mortality study conducted in Russia
reported a higher overall risk of breast cancer (SMR = 2.1,
95% CI 1.6–2.7) among women living in Chapaevsk [22].
From 1967 to 1987, a chemical plant from this area pro-
duced hexachlorocyclohexane, resulting in intense dioxin
contamination in the environment (air, soil, and drinking
water). High concentrations of dioxins were detected in
human milk and female workers' blood. However, no
details are given on the quality, completeness, and disease
classification of the mortality registration system, ham-
pering the assessment of the strengths, weaknesses, and
generalisability of this study.International Journal of Health Geographics 2008, 7:4 http://www.ij-healthgeographics.com/content/7/1/4
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Serum analysis of a subgroup of 981 women living in the
high exposure zones around Seveso is also suggestive of
an association between TCDD exposure and breast cancer
risk [15]. Serum samples were collected within five years
of the accident (1976) and analyzed for TCDD in 1996–
98. Fifteen women reported having been diagnosed with
breast cancer, and the diagnosis was confirmed by pathol-
ogy in 13 cases. However, this study suffered some limita-
tions, among which were the lack of increased incidence
in the whole cohort, the improper follow-up of the sub-
cohort and a RR that was no longer statistically significant
after exclusion of the two non-confirmed cases.
Our study, on the other hand, is consistent with two dif-
ferent hospital-based case-control studies, that found no
association between adipose levels of PCDD/Fs and breast
cancer risk [14,23]. They were however limited by their
small number of breast cancer cases (79 cases and 52 con-
trols, 22 cases and 19 controls, respectively), the measure-
ment of dioxin adipose concentrations at (or near) the
time of diagnosis, their hospital-based (and not popula-
tion-based) design, and the use of women undergoing
surgery for benign breast conditions as the control group
(which may result in over-matching).
Conclusion
Before speculating that dioxin anti-estrogenic activity has
greater effect on late-onset acquired breast cancer, we
must envisage some residual confounding. Considering
the inconclusive evidence from studies undertaken so far,
future large-scale population based studies that include
assessment of family history, breast cancer risk factors,
environmental exposures, standardized histopathology
reviews and molecular characterization are needed to lead
to new insights into the association between environmen-
tal dioxin exposure and breast cancer risk.
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